Get up to date, view state-of-the-art expert opinions by EPCCS faculty on major topics in cardiovascular disease and its relevance for European Primary Care.
Selected literature
Mallaina P, Lionis C, Rol H, et al.
CV-ASPIRE confirms that smoking is a significant predictor of long-term CV events thus underscores the importance of addressing this modifiable risk factor
Read more...
|
Selected literature
Schuler G, Adams V, Goto Y.
We summarise the molecular consequences of exercise and strategies to increase compliance to frequent exercise.
Read more...
|
Selected literature
JACC, March 2013. Exposure to second-hand tobacco smoke is a risk factor for coronary artery calcification, at least as strong as other well-established risk factors.
Read more...
|
Selected Literature
NEJM, March 2013. Reassuring results on the rates of gastrointestinal and intracranial bleeds with dabigatran from a new analysis of an FDA database.
Read more...
|
Selected literature
Lancet, february 2013. Calcium-channel blocker-based therapy gives more protection to non-obese patients than does diuretic-based therapy, whereas both regimes are effective in obese patients.
Read more...
|
Selected literature
Eur J Prev Cardiol. 2013 Statins reduce all-cause mortality and major coronary events both in patients with cardiovascular disease and in high-risk individuals without disease.
Read more...
|
Selected Literature
NEJM Feb 2013, Suggested protective effect of Mediterranean diet on cardiovascular disease now confirmed in randomised trial.
Read more...
|
Selected Literature
Dewilde WJ et al. for the WOEST study investigators
Lancet. Feb 2013. Omitting aspirin from antiplatelet regimen reduces the incidence of bleeding, without compromising safety in patients receiving oral anticoagulants undergoing PCI
Read more...
|
Selected Literature
Schulman S, Kearon O, Kakkar AK, et al
NEJM, Feb 2013. New information about the risks and benefits of extended prophylaxis with dabigatran in patients who have had venous thromboembolism (VTE)
Read more...
|
Selected Literature
NEJM, Feb 2013. New oral factor Xa inhibitor studied for prevention of recurrent venous thromboembolism
Read more...
|
EPCCS 2012 Webcast
View Prof. Martin Scherer, Universitätsklinikum Hamburg-Eppendorf Germany, discusses in case studies the dilemmas general practioners might face in managing cardiovascular disease in daily practice, as also presented during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes
Read more...
|
EPCCS 2012 Webcast
View Prof. Johan Wens, University of Antwerp, Belgium & General Practitioner, discuss the relation of Diabetes and Cardiovascular Disease and its relevance for primary care, as also presented during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes
Read more...
|
Smith SC Jr, Collins A, Ferrari R, et al. EHJ. 2012 Sep 17.
International cardiology group calls for aggressive public health goals. The Global Cardiovascular Disease Taskforce have proposed a set of aggressive measures to help achieve the goal to reduce premature mortality from non-communicable diseases by 25% by the year 2025.
Read more...
|
EPCCS 2012 Webcast
View Dr. Carlos Brotons, Barcelona, Spain, discuss the importance of diagnoses and management of patients with Familial Hypercholesterolaemia in general practice, as also presented during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes
Read more...
|
EPCCS 2012 Webcast
View Prof. Richard Hobbs, University of Oxford, United Kingdom, Chairman of EPCCS discussing the potential role of novel anticoagulants in primary care as also presented during the 5th Annual meeting of the EPCCS in Athens. Get up to date in only 3 minutes
Read more...
|
View all expert opinions of EPCCS 2012
Watch all faculty members of EPCCS 2012 provide 3 minute updates on key issues and new developments in cardiovascular disease relevant for primary care
Read more